Global CBD Consumer Health Market by Product (Medical OTC Products, Nutraceuticals), Distribution Channel (Online, Retail Pharmacies, Retail Stores) - Forecast 2023-2030

The CBD Consumer Health Market size was estimated at USD 9.31 billion in 2022, USD 10.77 billion in 2023, and is expected to grow at a CAGR of 15.78% to reach USD 30.07 billion by 2030.

The CBD consumer health market encompasses the sales, distribution, and consumption of cannabidiol (CBD) infused products aimed at improving overall health and wellness. The primary applications of these CBD-based products include pain management, stress relief, anxiety alleviation, and improvement in sleep quality. The increased awareness about the therapeutic benefits of CBD among consumers worldwide has improved the use of CBD consumer health products across the nutraceutical sector. Moreover, the relaxation of stringent regulations related to hemp cultivation and production has enhanced the production and availability of CBD consumer health products worldwide. The high costs associated with CBD consumer health products, along with inconsistent regulatory frameworks across different regions, have limited the product penetration of CBD consumer health products. However, the ongoing clinical trials investigating its effectiveness in treating various illnesses and continued investment from private investors and public sectors for exports and imports of medicinal CBD are expected to create growth opportunities for the CBD consumer health market in the coming years.

Regional Insights

The CBD consumer health market in the Americas is rapidly proliferating due to the legalization of cannabis cultivation and production, ongoing developments in CBD consumer health products, and increased consumer awareness toward the health benefits of CBD consumer health. Canadian consumers also show a growing interest in CBD for health and wellness purposes, as reflected by Health Canada's recent regulatory changes to provide easier access to cannabis-infused products. The rising number of clinical trials to evaluate CBD's potential benefits for various health conditions, such as anxiety, inflammation, pain management, and sleep disorders are expanding the scope for CBD consumer health products in the EMEA region. The Asia-Pacific region represents a rapidly evolving CBD consumer health market due to the flourishing nutraceutical and skincare industry, along with growing investments for CBD in the field of oncology.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the CBD Consumer Health Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CBD Consumer Health Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the CBD Consumer Health Market, highlighting leading vendors and their innovative profiles. These include Aurora Cannabis Inc., Canopy Growth Corporation, CBD American Shaman, CBDepot s.r.o, Charlotte’s Web Holdings, Inc., Columbia Care Inc., Croda International PLC, Curaleaf, Inc., CURE Pharmaceutical Holding Corp., CV Sciences, Inc., Elixinol LLC, Endoca BV, Gaia Botanicals, LLC, Global Cannabinoids Inc., HEXO Corp., Isodiol International Inc., Jazz Pharmaceuticals, Inc., Joy Organics LLC, Kazmira LLC, Koninklijke DSM N.V., Medical Marijuana, Inc., Medterra CBD, LLC., Noramco, Inc., and NuLeaf Naturals, LLC.

Market Segmentation & Coverage

This research report categorizes the CBD Consumer Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Medical OTC Products
    • CBD Analgesic Products
    • CBD Dermatology Products
    • CBD Mental Health Products
    • CBD Sleeping Aids Products
  • Nutraceuticals
    • CBD Sports Nutrition
    • CBD Vitamins & Dietary Supplements
    • CBD Weight Management & Wellbeing
• Distribution Channel
  • Online
  • Retail Pharmacies
  • Retail Stores

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

1. What is the market size and forecast of the CBD Consumer Health Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CBD Consumer Health Market?
3. What are the technology trends and regulatory frameworks in the CBD Consumer Health Market?
4. What is the market share of the leading vendors in the CBD Consumer Health Market?
5. Which modes and strategic moves are suitable for entering the CBD Consumer Health Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.